MedPath

Protein S Activity in Women With Unexplained Infertility

Conditions
Unexplained Female Infertility
Interventions
Diagnostic Test: Protein S activity
Registration Number
NCT03670758
Lead Sponsor
Esraa Gamal Ahmed
Brief Summary

This study will add:

Finding out an association between Protein S activity and unexplained female infertility.

Aim:

Study hypothesis:

In women with unexplained infertility protein S activity may be low.

Study question:

In women with unexplained infertility does protein S activity low?.

This study aims to assess the activity of protein S activity in women with unexplained infertility.

Objectives:

The main objective of this study is:

To determine the prevalence of Protein S activity with unexplained female infertility and to compare its prevalence in fertile women among women attending outpatient clinics at Ain Shams University Maternity Hospital.

Detailed Description

1. Type of Study: Case Control Study.

2. Study Setting: Ain Shams University Maternity Hospital: outpatient Infertility clinic and outpatient gynecology clinic.

3. Study Population: The study will include women with unexplained infertility (Group 1; cases) and fertile women who got pregnant and delivered at least once in the previous year with no history of recurrent abortions nor history of secondary infertility (Group 2; control).

Group 1: Will include 30 women with unexplained primary infertility; will be recruited from the outpatient infertility clinic.

Group 2; another 30 fertile women who got pregnant and delivered at least once in the previous year with no history of recurrent abortions; will recruited from outpatient gynecology clinic as control.

According to inclusion and exclusion criteria listed below.

Inclusion criteria:

1. Age: 18 - 35 years old.

2. Normal husband's semen analysis, (WHO criteria):

1. Count ≥ 15 million/ml.

2. Motility: ≥ 40%

3. Morphology: ≥ 4% normal morphology.

3. Documented ovulation.

4. Normal Follicle Stimulating Hormone, Luteinizing Hormone, Thyroid Stimulating Hormone, serum prolactin.

5. Patent Fallopian tubes.

6. Normal uterine cavity.

Exclusion criteria:

1. Patients aged less than 18 years or more than 35 years old.

2. Secondary infertility

3. Presence of male factor infertility

4. Anovulatory cycles.

5. Tubal block; Tubal disease is an important cause of infertility and should be specifically excluded.

6. Medical disorder that might affect pregnancy (e.g.: Diabetes, Thyroid dysfunction)

7. Patients with recurrent abortion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  1. Age: 18 - 35 years old.

  2. Normal husband's semen analysis, (WHO criteria):

    1. Count ≥ 15 million/ml.
    2. Motility: ≥ 40%
    3. Morphology: ≥ 4% normal morphology.
  3. Documented ovulation.

  4. Normal Follicle Stimulating Hormone, Luteinizing Hormone, Thyroid Stimulating Hormone, serum prolactin.

  5. Patent Fallopian tubes.

  6. Normal uterine cavity.

Exclusion Criteria
  1. Patients aged less than 18 years or more than 35 years old.
  2. Secondary infertility
  3. Presence of male factor infertility
  4. Anovulatory cycles.
  5. Tubal block; Tubal disease is an important cause of infertility and should be specifically excluded.
  6. Medical disorder that might affect pregnancy (e.g.: Diabetes, Thyroid dysfunction)
  7. Patients with recurrent abortion. -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 1Protein S activityWill include 30 women with unexplained primary infertility; will be recruited from the outpatient infertility clinic
Group 2Protein S activityanother 30 fertile women who got pregnant and delivered at least once in the previous year with no history of recurrent abortions; will recruited from outpatient gynecology clinic as control
Primary Outcome Measures
NameTimeMethod
Protein S activitysix months

venous blood sample

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath